In addition to their traditional antioxidant and antibacterial activities, phenolic compounds have also been found to regulate α-amylase activity, improve insulin resistance, enhance gut microbiota, and resist obesity. The gene discussed is INS; the disease is obesity due to melanocortin 4 receptor deficiency.